Baltimore sues another drugmaker amid high prices

Baltimore has filed an antitrust lawsuit against the maker of a drug that treats prostate cancer, alleging that the company worked to delay generic competition from coming to the market so it could continue to reap the benefits of its monopoly. The lawsuit, filed last week, is one of several the city has initiated in recent ...

To purchase a reprint of this article, contact reprints@thedailyrecord.com.

Leave a Reply

Your email address will not be published. Required fields are marked *